MMP9 and myeloid sarcoma: In particular, the MMP-9:TIMP-1 ratio seems to be a very suitable and easily measurable biomarker for the continuous inflammation in MS and may be predictive of relapsing-remitting MS, which is detected by magnetic resonance imaging [163].